---
document_datetime: 2023-09-21 20:55:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/elmiron-epar-all-authorised-presentations_en.pdf
document_name: elmiron-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7768443
conversion_datetime: 2025-12-23 02:07:20.298118
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number                    | (Invented) name   | Strength      | Pharmaceutical Form                       | Route of Administration    | Immediate Packaging                                 | Pack size                             |
|-----------------------------------|-------------------|---------------|-------------------------------------------|----------------------------|-----------------------------------------------------|---------------------------------------|
| EU/1/17/1189/001 EU/1/17/1189/002 | elmiron           | 100 mg 100 mg | Capsule, hard Capsule, hard Capsule, hard | Oral use Oral use Oral use | bottle (HDPE) blister (PVC/Aclar/alu) bottle (HDPE) | 90 capsules 90 capsules 300 (3 x 100) |
|                                   | elmiron           |               |                                           |                            |                                                     |                                       |
| EU/1/17/1189/003                  | elmiron           | 100 mg        |                                           |                            |                                                     | capsules                              |